VANGUARD GROUP INC

Holdings History for Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Symbol: IMNM on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 4,524,952 shares
Security Ownership %: 5.2%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Immunome Inc. Common Stock, par value $0.0001 per share (IMNM)

29 Jul 2025 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,524,952 shares of Immunome Inc. Common Stock, par value $0.0001 per share (IMNM). This represents 5.2% ownership of the company. In their previous filing dated 30 Jan 2025, VANGUARD GROUP INC had reported owning 3,003,438 shares, indicating an increase of +51%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
The Vanguard Group	5.2%	+7.8%	$38,552,591	4,524,952	+1,521,514	+51%	$8.52	13G	30 Jun 2025	29 Jul 2025, 13:00
The Vanguard Group	4.8%		$21,324,410	3,003,438			$7.10	13G/A	31 Dec 2024	30 Jan 2025, 21:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	0%	+0%	$57,304,359	4,893,626	+368,674	+8.1%	$11.71	Q3 2025
30 Jun 2025	0%	+0%	$42,082,054	4,524,952	+217,761	+5.1%	$9.30	Q2 2025
31 Mar 2025	0%	+0%	$28,987,396	4,307,191	+1,303,753		$6.73	Q1 2025
31 Dec 2024	0%	-0%	$31,896,511	3,003,438	-128,130	-4.1%	$10.62	Q4 2024
30 Sep 2024	0%	+0%	$45,783,525	3,131,568	+210,356	+7.2%	$14.62	Q3 2024
30 Jun 2024	0%	+0%	$35,346,665	2,921,212	+901,474	+45%	$12.10	Q2 2024
31 Mar 2024	0%	+0%	$49,847,134	2,019,738	+279,712	+16%	$24.68	Q1 2024
31 Dec 2023	0%	+0%	$18,618,278	1,740,026	+1,343,697	+339%	$10.70	Q4 2023
30 Sep 2023	0%	+0%	$3,309,347	396,329	+22,451	+6%	$8.35	Q3 2023
30 Jun 2023	0%	0%	$2,957,375	373,878	0		$7.91	Q2 2023
31 Mar 2023	0%	0%	$1,865,652	373,878	0		$4.99	Q1 2023
31 Dec 2022	0%	0%	$826,271	373,878	+193	+0.05%	$2.21	Q4 2022
30 Sep 2022	0%	0%	$1,659,000	373,685	+3,149	+0.85%	$4.44	Q3 2022
30 Jun 2022	0%	0%	$1,189,000	370,536	0		$3.21	Q2 2022
31 Mar 2022	0%	-0%	$2,105,000	370,536	-5,822	-1.5%	$5.68	Q1 2022
31 Dec 2021	0%	+0%	$4,878,000	376,358	+3,878	+1%	$12.96	Q4 2021
30 Sep 2021	0%	+0%	$9,070,000	372,480	+70,388	+23%	$24.35	Q3 2021
30 Jun 2021	0%	+0%	$5,226,000	302,092	+147,863	+96%	$17.30	Q2 2021
31 Mar 2021	0%	+0%	$5,225,000	154,229	+154,229	NEW	$33.88	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.